NCT03590197View on ClinicalTrials.gov

Effect of Melatonin on Seizure Outcome, Neuronal Damage and Quality of Life in Patients With Generalized Epilepsy

PHASE4CompletedINTERVENTIONAL

Enrollment

104

Participants

Timeline

Start Date

August 6, 2018

Primary Completion Date

March 3, 2020

Study Completion Date

April 12, 2020

Conditions

Generalized Epilepsy

Interventions

DRUG

Melatonin 3 mg

Melatonin 3 mg/ day with Valproate

OTHER

Placebo

Placebo with Valproate

Trial Locations (1)

751019

All India Institute of Medical Sciences (AIIMS), Bhubaneswar

All Listed Sponsors

lead

All India Institute of Medical Sciences, Bhubaneswar

OTHER

NCT03590197 - Effect of Melatonin on Seizure Outcome, Neuronal Damage and Quality of Life in Patients With Generalized Epilepsy | Biotech Hunter | Biotech Hunter